Accelerating transformation in Healthcare & Life Sciences

Making valuable progress in Healthcare & Life Sciences requires businesses strike a balance between patient requirements, market opportunity, and regulatory compliance: all while continuing to innovate.

Explore
    Sanofi
    Bristol Myers Squibb
    AstraZeneca
    Debiopharm,
    Novartis
    GSK
    Enel
    Roche

Introducing Total Innovation for
Healthcare and Life Sciences

Wazoku’s Total Innovation provides a transformative framework for fostering innovation across the healthcare and life sciences sectors.

By addressing the challenges of fragmented data, siloed systems, and regulatory complexities, our centralized platform enables organizations to harness the collective intelligence of their ecosystems. Leveraging advanced AI methodologies, including our proprietary Challenge Driven Innovation™ (CDI), we empower these sectors to accelerate research, improve patient outcomes, and drive transformative breakthroughs in medicine and healthcare delivery.

Learn how to transform patient pathways through Open Innovation from Wazoku

 Learn more

How Wazoku Powers Your Innovation

1. Connected Data

Break free from "Black Box Innovation," where critical data remains isolated in silos. Wazoku’s Innovation Ecosystem Platform centralizes innovation-related data for the health and life sciences sector, enabling:

  • Consolidated insights to advance medical breakthroughs
  • AI-driven analysis for precision medicine and treatment innovation
  • Enhanced visibility across R&D and innovation portfolios
  • Streamlined decision-making to accelerate patient-focused solutions
Learn more →

2. Systems Thinking

Adopt a holistic approach tailored to the health and life sciences sector, recognizing the interconnected nature of innovation. Wazoku’s framework:

  • Maps interdependencies across R&D, clinical trials, and healthcare initiatives
  • Ensures alignment between innovation projects and patient-centric goals
  • Facilitates coordinated efforts across multidisciplinary teams
  • Optimizes resource allocation to advance medical and scientific breakthroughs
Learn more →

3. Connected Collective Intelligence

Leverage the collective knowledge of your health and life sciences ecosystem with Wazoku’s agentic AI, Jen, empowering:

  • Employee ideation to drive medical innovation
  • Collaboration with partners, suppliers, and healthcare providers
  • Integration of patient and customer insights
  • Contributions from external networks and research communities
  • Cross-functional problem-solving for complex healthcare challenges
Learn more →

4. Accelerated Discovery

Accelerate innovation cycles in health and life sciences while minimizing risks with Wazoku’s AI-enabled approach:

  • Challenge Driven Innovation™ (CDI) for targeted solutions
  • AI-enhanced trend identification in medical advancements
  • Automated technology scouting for cutting-edge treatments
  • Strategic opportunity mapping for healthcare breakthroughs
  • Reduced project risks and costs in R&D and clinical innovations
Learn more →
Quadrants of innovation

We are the Total Innovation Ecosystem

Whether you're addressing everyday challenges or future-proofing your business, Wazoku offers a comprehensive, AI-connected ecosystem of software, services, and solutions. From insight to impact, Wazoku enables you to innovate and succeed at scale, driving transformative outcomes across the health and life sciences sectors.

Request a Demo

Challenge Driven Innovation in the Drug Development Pipeline

Wazoku addresses challenges in the health sciences industry by leveraging a Challenge-Driven Innovation (CDI) pipeline that spans the entire drug development process.

Target Identification

Wazoku collaborates with leading companies like AstraZeneca to uncover novel disease mechanisms. This partnership enables the identification of preclinical compounds, paving the way for groundbreaking treatments.

Target Validation

In this stage, Wazoku aids companies such as Roche in identifying biological targets for conditions like obesity. By ensuring the validity of these potential drug targets, Wazoku supports the foundation of successful drug development.

Lead Discovery

Wazoku partners with entities like Bristol Myers Squibb to develop innovative tools, such as PET imaging probes. These tools are crucial for the visualization and quantification of oligonucleotide exposure, advancing the discovery of new drug leads.

Lead Optimization

During the lead optimization phase, Wazoku facilitates rapid detection methods for intermolecular interactions. This accelerates the refinement of potential drug candidates, making the development process more efficient.

Preclinical

In collaboration with organizations like Novartis, Wazoku creates preclinical models for diseases such as age-related macular degeneration. These models are essential for testing drug efficacy and safety before clinical trials.

Clinical Trials

Wazoku helps companies like Allergan overcome key barriers to patient participation in clinical trials. By addressing these challenges, Wazoku ensures that trials are more inclusive and representative, leading to more robust and reliable data.

Through these strategic partnerships and innovative solutions, Wazoku drives significant advancements in each stage of the drug development pipeline, ultimately contributing to the creation of effective health solutions.

Transforming Therapeutic Development

Scientists

Benefits of Open Innovation

According to Deloitte Analysis, there is a 3X more likely to succeed when drugs are sourced via Open Innovation.

Open Innovation vs Traditional Methods

Drug sourced via Open Innovation have a higher chance of later phase clinical success among 280+ bio pharma companies.

Get the Report

Effective Across All Therapeutic Areas

Wazoku and Open Innovation play significant roles in addressing challenges in various therapeutic areas by fostering collaboration, leveraging diverse expertise, and accelerating the development of innovative solutions.

Here's how we support solving challenges in the specified therapeutic areas:

Cardiology

Discover the Challenges

Oncology

Discover the Challenges

Neurology

Discover the Challenges

Endocrinology

Discover the Challenges

Gastroenterology

Discover the Challenges

Hematology

Discover the Challenges

Infectious Diseases

Discover the Challenges

Dermatology

Discover the Challenges

Interested in running an Open Innovation Challenge?

Start Your Challenge
Customer Stories
Debiopharm logo

"We are proud that the pool of international innovators from the Wazoku Crowd have given fresh insights to help us in developing simplified vaccine solutions."
Bertrand Ducrey, CEO of Debiopharm

Read more
Customer Stories
GlaxoSmithKline logo

Read GlaxoSmithKline's Customer Story and learn how Wazoku's unique approach to innovation helped them solve their business challenges

Read more
Customer Stories
AstraZeneca logo

Read AstraZeneca's Customer Story and learn how Wazoku's unique approach to innovation helped them solve their business challenges

Read more
Customer Stories
Roche logo

Discover how Roche is transforming R&D through Open Innovation leveraging internal and external networks for groundbreaking solutions.

Read more

Explore our latest insights on Health and Life Sciences

Scientist

Open Innovation in Pharmaceutical R&D: A Paradigm Shift

Read article →

Roche: The Power of Open Innovation to Solve Problems

Read article →

Unlocking Success: The Power of Open Innovation

Read article →

Sign up to the Wazoku Health & Life Sciences newsletter

We'll keep you up to date on how we're changing the world one idea at a time

Transform your Health and Life Sciences Innovation

Explore Challenge Driven Innovation
Scientists

Unlock the potential of the "Challenge Driven Innovation® Process" to revolutionize your approach to problem-solving and solution development in the health and life sciences sectors. This proven framework will guide your organization from identifying key challenges to scaling effective, market-ready solutions.

The "Challenge Driven Innovation® Process" is a comprehensive framework designed to drive innovation and create new value within the health and life sciences sectors. This process guides organizations through a systematic journey from identifying challenges to scaling viable solutions.

It is segmented into three key phases: Ideate, Incubate, and Scale.

Light bulb
Ideate Phase

  1. Ambition: Define the overarching goals and vision for innovation.
  2. Hunting Zones: Identify key areas of opportunity within the health and life sciences landscape.
  3. Problem Statement: Clearly articulate the specific challenges to be addressed.
  4. Solution Development: Generate and refine potential solutions to the identified problems.

Orbits
Incubate Phase

  1. Requirements Definition: Establish the necessary criteria and requirements for solution implementation.
  2. Solution Validation: Test and validate solutions through rigorous experimentation.
  3. Customer Trials: Conduct trials with target customers to gather feedback and insights.
  4. Early Sales: Begin initial sales to validate market readiness and adoption.

Graph
Scale Phase

Transition validated solutions into the market by building customer bases, enhancing capabilities, and scaling operations to achieve widespread impact.

Throughout this process, iterative research and experimentation loops are employed to continually refine hypotheses and learnings, ensuring that each solution is robust and effective before scaling. This structured approach not only accelerates innovation but also ensures that new solutions are aligned with the unique needs and challenges of the health and life sciences industries.

Ready to innovate?

Discover how the "Challenge Driven Innovation® Process" can drive growth and create new value for your organization.

Get The Report